{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T12:22:30Z","timestamp":1791030150319,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1124\/dmd.106.009746","type":"journal-article","created":{"date-parts":[[2006,6,9]],"date-time":"2006-06-09T00:48:37Z","timestamp":1149814117000},"page":"1624-1631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":159,"title":["In Vivo Blood-Brain Barrier Transport of Oxycodone in the Rat: Indications for Active Influx and Implications for Pharmacokinetics\/Pharmacodynamics"],"prefix":"10.1016","volume":"34","author":[{"given":"Emma","family":"Bostr\u00f6m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrika S.H.","family":"Simonsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margareta","family":"Hammarlund-Udenaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.106.009746_bib1","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1471-4159.1987.tb00954.x","article-title":"Regional cerebral glucose phosphorylation and blood flow after insertion of a microdialysis fiber through the dorsal hippocampus in the rat.","volume":"49","author":"Benveniste","year":"1987","journal-title":"J Neurochem"},{"key":"10.1124\/dmd.106.009746_bib2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0022-3565(25)20113-6","article-title":"Poor permeability of morphine 3-glucuronide and morphine 6-glucuronide through the blood-brain barrier in the rat.","volume":"278","author":"Bickel","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.106.009746_bib3","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1002\/rcm.1658","article-title":"The use of liquid chromatography\/mass spectrometry for quantitative analysis of oxycodone, oxymorphone and noroxycodone in Ringer solution, rat plasma and rat brain tissue.","volume":"18","author":"Bostr\u00f6m","year":"2004","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1124\/dmd.106.009746_bib4","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/jps.20327","article-title":"Oxycodone pharmacokinetics and pharmacodynamics in the rat in the presence of the P-glycoprotein inhibitor PSC833.","volume":"94","author":"Bostr\u00f6m","year":"2005","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.106.009746_bib5","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1046\/j.1471-4159.2003.01990.x","article-title":"Evidence for an active transport of morphine-6-beta-d-glucuronide but not P-glycoprotein-mediated at the blood-brain barrier.","volume":"86","author":"Bourasset","year":"2003","journal-title":"J Neurochem"},{"key":"10.1124\/dmd.106.009746_bib6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bcp.2003.08.027","article-title":"Variable modulation of opioid brain uptake by P-glycoprotein in mice.","volume":"67","author":"Dagenais","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.106.009746_bib7","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1172\/JCI114279","article-title":"Plasma binding and transport of diazepam across the blood-brain barrier. No evidence for in vivo enhanced dissociation.","volume":"84","author":"Dubey","year":"1989","journal-title":"J Clin Investig"},{"key":"10.1124\/dmd.106.009746_bib8","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/01.cad.0000175584.86198.ac","article-title":"In vitro partition of irinotecan (CPT-11) in human volunteer blood: the influence of concentration, gender and smoking.","volume":"16","author":"Dumez","year":"2005","journal-title":"Anticancer Drugs"},{"key":"10.1124\/dmd.106.009746_bib9","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/0028-3908(73)90039-7","article-title":"On the measurement of extracellular space in slices prepared from different rat brain areas.","volume":"12","author":"Goodman","year":"1973","journal-title":"Neuropharmacology"},{"key":"10.1124\/dmd.106.009746_bib10","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0006-8993(98)00572-1","article-title":"Changes in blood-brain barrier permeability associated with insertion of brain cannulas and microdialysis probes.","volume":"803","author":"Groothuis","year":"1998","journal-title":"Brain Res"},{"key":"10.1124\/dmd.106.009746_bib11","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1124\/dmd.105.007211","article-title":"Brain distribution of cetirizine enantiomers: comparison of three different tissue-to-plasma partition coefficients: K(p), K(p,u), and K(p,uu).","volume":"34","author":"Gupta","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.106.009746_bib12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0169-409X(00)00109-5","article-title":"The use of microdialysis in CNS drug delivery studies. Pharmacokinetic perspectives and results with analgesics and antiepileptics.","volume":"45","author":"Hammarlund-Udenaes","year":"2000","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/dmd.106.009746_bib13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1023\/A:1012080106490","article-title":"Drug equilibration across the blood-brain barrier\u2014pharmacokinetic considerations based on the microdialysis method.","volume":"14","author":"Hammarlund-Udenaes","year":"1997","journal-title":"Pharm Res (NY)"},{"key":"10.1124\/dmd.106.009746_bib14","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0022-3565(24)38239-4","article-title":"Active transport of fentanyl by the blood-brain barrier.","volume":"289","author":"Henthorn","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.106.009746_bib15","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1023\/A:1007557028313","article-title":"Distribution of gacyclidine enantiomers in spinal cord extracellular fluid.","volume":"17","author":"Hoizey","year":"2000","journal-title":"Pharm Res (NY)"},{"key":"10.1124\/dmd.106.009746_bib16","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0378-4347(00)83176-X","article-title":"An improved method for the simultaneous determination of morphine and its principal glucuronide metabolites.","volume":"430","author":"Joel","year":"1988","journal-title":"J Chromatogr"},{"key":"10.1124\/dmd.106.009746_bib17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0169-2607(98)00067-4","article-title":"Xpose\u2014an S-PLUS based population pharmacokinetic\/pharmacodynamic model building aid for NONMEM.","volume":"58","author":"Jonsson","year":"1999","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1124\/dmd.106.009746_bib18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0006-8993(00)02758-X","article-title":"The 4F2hc\/LAT1 complex transports L-DOPA across the blood-brain barrier.","volume":"879","author":"Kageyama","year":"2000","journal-title":"Brain Res"},{"key":"10.1124\/dmd.106.009746_bib19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.canlet.2005.06.051","article-title":"Implications of genetic polymorphisms in drug transporters for pharmacotherapy.","volume":"234","author":"Kerb","year":"2006","journal-title":"Cancer Lett"},{"key":"10.1124\/dmd.106.009746_bib20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/bdd.257","article-title":"Distribution of ifosfamide and metabolites between plasma and erythrocytes.","volume":"22","author":"Kerbusch","year":"2001","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/dmd.106.009746_bib21","first-page":"277","article-title":"Hematology reference values for peripheral blood of laboratory rats.","volume":"36","author":"Leonard","year":"1986","journal-title":"Lab Anim Sci"},{"key":"10.1124\/dmd.106.009746_bib22","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1023\/A:1011938112599","article-title":"Effect of GF120918, a potent P-glycoprotein inhibitor, on morphine pharmacokinetics and pharmacodynamics in the rat.","volume":"15","author":"Letrent","year":"1998","journal-title":"Pharm Res (NY)"},{"key":"10.1124\/dmd.106.009746_bib23","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1602\/neurorx.2.1.86","article-title":"Blood-brain barrier active efflux transporters: ATP-binding cassette gene family.","volume":"2","author":"Loscher","year":"2005","journal-title":"NeuroRx"},{"key":"10.1124\/dmd.106.009746_bib24","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/01616412.1999.11740975","article-title":"Saturable transport of gabapentin at the blood-brain barrier.","volume":"21","author":"Luer","year":"1999","journal-title":"Neurol Res"},{"key":"10.1124\/dmd.106.009746_bib25","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/S0024-3205(99)00148-4","article-title":"Opioid binding profiles of new hydrazone, oxime, carbazone and semicarbazone derivatives of 14-alkoxymorphinans.","volume":"64","author":"Monory","year":"1999","journal-title":"Life Sci"},{"key":"10.1124\/dmd.106.009746_bib26","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1124\/jpet.105.094276","article-title":"Comparison of the antinociceptive response to morphine and morphine-like compounds in male and female Sprague-Dawley rats.","volume":"316","author":"Peckham","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.106.009746_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0014-2999(97)10082-6","article-title":"Distribution of apomorphine enantiomers in plasma, brain tissue and striatal extracellular fluid.","volume":"329","author":"Sam","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/dmd.106.009746_bib28","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/0006-8993(88)90816-5","article-title":"Determination of rat cerebral cortical blood volume changes by capillary mean transit time analysis during hypoxia, hypercapnia and hyperventilation.","volume":"454","author":"Shockley","year":"1988","journal-title":"Brain Res"},{"key":"10.1124\/dmd.106.009746_bib29","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1399-6576.1998.tb05169.x","article-title":"Comparison of analgesic efficacy of oxycodone and morphine in postoperative intravenous patient-controlled analgesia.","volume":"42","author":"Silvasti","year":"1998","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1124\/dmd.106.009746_bib30","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1002\/jps.10224","article-title":"Investigation of transport mechanism of pentazocine across the blood-brain barrier using the in situ rat brain perfusion technique.","volume":"91","author":"Suzuki","year":"2002","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.106.009746_bib31","first-page":"F835","article-title":"Drainage of interstitial fluid from different regions of rat brain.","volume":"246","author":"Szentistvanyi","year":"1984","journal-title":"Am J Physiol"},{"key":"10.1124\/dmd.106.009746_bib32","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0022-3565(24)36531-0","article-title":"The entry of [D-penicillamine2,5]enkephalin into the central nervous system: saturation kinetics and specificity.","volume":"280","author":"Thomas","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.106.009746_bib33","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0163-7258(81)90077-2","article-title":"Concepts basic to pharmacokinetics.","volume":"12","author":"Tozer","year":"1981","journal-title":"Pharmacol Ther"},{"key":"10.1124\/dmd.106.009746_bib34","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1023\/B:PHAM.0000041468.00587.c6","article-title":"An integrated model for the analysis of pharmacokinetic data from microdialysis experiments.","volume":"21","author":"Tunblad","year":"2004","journal-title":"Pharm Res (NY)"},{"key":"10.1124\/dmd.106.009746_bib35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejps.2004.09.009","article-title":"Influence of probenecid on the delivery of morphine-6-glucuronide to the brain.","volume":"24","author":"Tunblad","year":"2005","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.106.009746_bib36","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1023\/A:1023250900462","article-title":"Morphine blood-brain barrier transport is influenced by probenecid co-administration.","volume":"20","author":"Tunblad","year":"2003","journal-title":"Pharm Res (NY)"},{"key":"10.1124\/dmd.106.009746_bib37","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s00213-003-1718-1","article-title":"Brain penetration of methadone (R)- and (S)-enantiomers is greatly increased by P-glycoprotein deficiency in the blood-brain barrier of Abcb1a gene knockout mice.","volume":"173","author":"Wang","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/dmd.106.009746_bib38","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1038\/sj.bjp.0703759","article-title":"Modelling of the blood-brain barrier transport of morphine-3-glucuronide studied using microdialysis in the rat: involvement of probenecid-sensitive transport.","volume":"131","author":"Xie","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1124\/dmd.106.009746_bib39","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1023\/A:1011929910782","article-title":"Blood-brain barrier equilibration of codeine in rats studied with microdialysis.","volume":"15","author":"Xie","year":"1998","journal-title":"Pharm Res (NY)"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624036109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624036109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.106.009746","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T18:10:11Z","timestamp":1739902211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624036109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0090955624036109"],"URL":"https:\/\/doi.org\/10.1124\/dmd.106.009746","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In Vivo Blood-Brain Barrier Transport of Oxycodone in the Rat: Indications for Active Influx and Implications for Pharmacokinetics\/Pharmacodynamics","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.106.009746","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2006 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}